KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Income from Continuing Operations (2016 - 2025)

Boston Scientific's Income from Continuing Operations history spans 17 years, with the latest figure at 669000000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 19.04% year-over-year to 669000000.0; the TTM value through Dec 2025 reached 2892000000.0, up 56.66%, while the annual FY2025 figure was 2892000000.0, 56.66% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 669000000.0 at Boston Scientific, down from 756000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 795000000.0 in Q2 2025 and bottomed at 93000000.0 in Q4 2021.
  • The 5-year median for Income from Continuing Operations is 380000000.0 (2021), against an average of 403450000.0.
  • The largest annual shift saw Income from Continuing Operations skyrocketed 3310.0% in 2021 before it tumbled 67.45% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 93000000.0 in 2021, then surged by 51.61% to 141000000.0 in 2022, then skyrocketed by 257.45% to 504000000.0 in 2023, then rose by 11.51% to 562000000.0 in 2024, then grew by 19.04% to 669000000.0 in 2025.
  • Per Business Quant, the three most recent readings for BSX's Income from Continuing Operations are 669000000.0 (Q4 2025), 756000000.0 (Q3 2025), and 795000000.0 (Q2 2025).